Why the study?
Does NG-monomethyl L-arginine (LNMMA) inhibit EDRF-stimulated cyclic GMP accumulation in bovine endothelial and vascular smooth muscle cells?
Population
Bovine pulmonary artery endothelial cells and vascular smooth muscle cells in cocultures and superfused…
Comparison
NG-monomethyl L-arginine (LNMMA) 30-300 microM vs Absence of LNMMA (control buffer)
Design
Preclinical
Authors
Loading...
LNMMA selectively blocks EDRF-driven cGMP in endothelial-smooth muscle cocultures; leaves open its value as an in vivo research tool or clinical candidate.
Does NG-monomethyl L-arginine (LNMMA) inhibit EDRF-stimulated cyclic GMP accumulation in bovine endothelial and vascular smooth muscle cells?
LNMMA acts as a specific inhibitor of EDRF production or release at the level of the endothelial cell.
Johns et al. (1990) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: